Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Literature DB >> 20686748

Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

J S Yudkin, B Richter, E A M Gale.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2010 PMID： 20686748 DOI： 10.1007/s00125-010-1864-z

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

45 in total

1. Intensified glucose control in type 2 diabetes--whose agenda?

Authors: John S Yudkin; Bernd Richter; Edwin A M Gale
Journal: Lancet Date: 2010-11-18 Impact factor: 79.321

2. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245

3. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors:
Journal: JAMA Date: 1967-12-11 Impact factor: 56.272

Review 4. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

Authors: P R Hebert; M Moser; J Mayer; R J Glynn; C H Hennekens
Journal: Arch Intern Med Date: 1993-03-08

5. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

Authors: S Vijan; T P Hofer; R A Hayward
Journal: Ann Intern Med Date: 1997-11-01 Impact factor: 25.391

Review 6. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

Authors: Sarah Lewington; Gary Whitlock; Robert Clarke; Paul Sherliker; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Richard Peto; Rory Collins
Journal: Lancet Date: 2007-12-01 Impact factor: 79.321

7. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

Authors: Elbert S Huang; Qi Zhang; Niren Gandra; Marshall H Chin; David O Meltzer
Journal: Ann Intern Med Date: 2008-07-01 Impact factor: 25.391

8. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

9. Let's not turn elderly people into patients. Wanted: age adjusted outcomes.

Authors: Erik Buskens
Journal: BMJ Date: 2009-03-31

10. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

Authors: Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; Shanelle Wijesuriya; Rupa Sivakumaran; Sarah Nethercott; David Preiss; Sebhat Erqou; Naveed Sattar
Journal: Lancet Date: 2009-05-23 Impact factor: 79.321

41 in total

Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

1. Intensified glucose control in type 2 diabetes--whose agenda?

2. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

3. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Review 4. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

5. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

Review 6. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

7. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

8. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

9. Let's not turn elderly people into patients. Wanted: age adjusted outcomes.

10. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

1. Managing hyperglycaemia in patients with type 2 diabetes and known cardiovascular disease.

2. Intervention at the very early stage of type 2 diabetes.

3. Intensified glucose lowering in type 2 diabetes: time for a bolder reappraisal.

Review 4. Endocrinology research-reflecting on the past decade and looking to the next.

5. [Cardial target-organ damage in diabetes].

6. Death during intensive glycemic therapy of diabetes: mechanisms and implications.

Review 7. Using insulin in type 2 diabetes: in need of a renaissance?

8. In pursuit of normoglycaemia: the overtreatment of type 2 diabetes in general practice.

9. Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management.

Review 10. Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors.